New hope for patients who Can't take standard chemo
NCT ID NCT07441681
Summary
This study aims to find the best treatment for people with advanced head and neck cancer who cannot safely take the standard chemotherapy drug, cisplatin. It will compare two different drug combinations, each given alongside targeted radiation therapy, in about 454 patients. The goal is to see which approach better controls the cancer and helps patients live longer without it getting worse.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICAL STAGE I HPV-MEDIATED (P16-POSITIVE) OROPHARYNGEAL CARCINOMA AJCC V8 are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
Explore the condition pages connected to this study.